C50.612
Malignant neoplasm of axillary tail of left female breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the axillary tail of the left female breast refers to a type of breast cancer located in the tail of the breast directed toward the armpit (axillary region). This area is part of the breast where cancer can develop and may spread to nearby tissues or lymph nodes. Recognizing and understanding this specific diagnosis helps patients realize the importance of timely diagnosis and treatment options for their condition.
Causes & Symptoms
Clinical Causes: Genetic factors that increase cancer risk Hormonal influences, especially prolonged exposure to estrogen Family history of breast cancer Previous history of benign breast disease Environmental and lifestyle factors, such as radiation exposure, alcohol consumption, and obesity Age-related risk, with higher incidence in older women Certain inherited gene mutations (e.g., BRCA1 and BRCA2)
Key Symptoms: A painless lump or thickening in the upper outer quadrant of the breast, near the axillary tail Changes in the size, shape, or appearance of the breast Skin changes over the affected area, such as redness or dimpling Nipple changes, including inversion or discharge Swelling or enlarged lymph nodes in the armpit Persistent pain in the breast or armpit area that doesn't go away Unexplained weight loss or fatigue in advanced cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical examination and several imaging and laboratory tests:
Treatment Protocols: Management of malignant neoplasm of the axillary tail typically involves multidisciplinary approaches:
Clinical Advice & FAQs
Billing Guidance
Is C50.612 a billable ICD-10 code?
Yes, C50.612 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.612?
Clinical documentation must specify the nature of Malignant neoplasm of axillary tail of left female breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference